From HPV Detection to Cancer Prevention: The Role of Infection Persistence, Genotype, and Anatomical Site in HPV-Associated Cancers
7 affiliations
- 1Health Deputy, Birjand University of Medical Sciences, Birjand 9717853577, Iran
- 2Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran
- 3Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan
- 4Shiraz Health Assistant Department, Shiraz University of Medical Sciences, Shiraz 7193711351, Iran
- 5Faculty of Health Sciences, Cyprus International University, Nicosia 99258, Cyprus
- 6Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran
- 7College of General Education, Kookmin University, Seoul 02707, Republic of Korea
Abstract
Background/Objectives: Most HPV infections are transient, but persistent high-risk infection, particularly with HPV16, is among the most important determinants of progression to HPV-associated precancer and cancer. The role of genotype, infection persistence, and anatomical site varies across cervical, oropharyngeal, anal, vaginal, vulvar, and penile cancers. This review synthesizes evidence to clarify how these factors shape cancer risk and prevention. Methods: This structured narrative review used iterative, topic-specific searches in PubMed, Scopus, Web of Science, and Google Scholar without a publication-year restriction and was limited to English-language sources. Search terms were adapted to each database and thematic question. Original empirical studies and secondary data analyses informed direct quantitative discussion, whereas reviews, meta-analyses, guidelines, consensus statements, and authoritative reports were used principally for context. Evidence was synthesized qualitatively because study designs, populations, anatomical sites, assays, outcomes, and clinical purposes differed substantially; no new meta-analysis was performed. Results: The most developed longitudinal and screening evidence concerned cervical cancer, whereas evidence for several non-cervical sites was smaller and more heterogeneous. HPV16 was the most important genotype in most cancers examined. The role of HPV18 and other high-risk genotypes varied depending on the cancer site, tissue type, and geographic region. Most transient infections do not lead to cancer; however, persistent high-risk HPV infection, particularly HPV16, was associated with high-grade lesions and an increased risk of cancer. Vaccination was associated with a reduction in high-grade lesions and invasive cancer in population-based studies. Self-sampling and urine testing had practical value when individuals with positive results proceeded to triage, treatment, and follow-up. Conclusions: Three key questions exist for assessing the risk of HPV-associated cancers: Where has the persistent infection occurred? Which genotype is involved? And can the healthcare system intervene before progression to cancer? In cervical cancer, vaccination, screening, triage, and treatment are linked within the most developed prevention pathway. For anal cancer, prevention is more strongly focused on high-risk groups and diagnostic capacity. In oropharyngeal cancer, HPV is important for understanding etiology and prognosis, but there is still no established population screening pathway. Evidence for vaginal, vulvar, and penile cancers must be interpreted separately by site.
Related
- Cervicovaginal lipid mediator profiles during high-risk HPV infection associated with subsequent viral clearance or persistence: an exploratory pilot study
- Persistence of viral full-length genomic RNA and replication-associated RNA transcripts and proteins in sheep tissues following acute Crimean-Congo hemorrhagic fever virus infection
- Catheter-Associated Urinary Tract Infection Prevention Practices in US Hospitals
- Aligning Antimicrobial Stewardship and Infection Prevention Through Repeated Assessment and Feedback: A Multisite Quality Improvement Initiative in Viet Nam
- MRSA Knowledge, Infection-Prevention Practices, and Antibiotic Use Without Clinician Consultation Among Hajj Pilgrims Arriving in Madinah, Saudi Arabia: A Cross-Sectional Study †
BibTeX
@article{jouya2026from,
title = {{From HPV Detection to Cancer Prevention: The Role of Infection Persistence, Genotype, and Anatomical Site in HPV-Associated Cancers}},
author = {Sara Jouya and Zahra Shahabinia and Mai Abdel Haleem A. Abusalah and Afrooz Mazidimoradi and Leila Allahqoli and Hamid Salehiniya and Do-Youn Lee},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15208098},
url = {https://www.mdpi.com/2077-0383/15/20/8098},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - From HPV Detection to Cancer Prevention: The Role of Infection Persistence, Genotype, and Anatomical Site in HPV-Associated Cancers
AU - Sara Jouya
AU - Zahra Shahabinia
AU - Mai Abdel Haleem A. Abusalah
AU - Afrooz Mazidimoradi
AU - Leila Allahqoli
AU - Hamid Salehiniya
AU - Do-Youn Lee
PY - 2026
DA - 2026/10/19
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15208098
UR - https://www.mdpi.com/2077-0383/15/20/8098
AB - Background/Objectives: Most HPV infections are transient, but persistent high-risk infection, particularly with HPV16, is among the most important determinants of progression to HPV-associated precancer and cancer. The role of genotype, infection persistence, and anatomical site varies across cervical, oropharyngeal, anal, vaginal, vulvar, and penile cancers. This review synthesizes evidence to clarify how these factors shape cancer risk and prevention. Methods: This structured narrative review used iterative, topic-specific searches in PubMed, Scopus, Web of Science, and Google Scholar without a publication-year restriction and was limited to English-language sources. Search terms were adapted to each database and thematic question. Original empirical studies and secondary data analyses informed direct quantitative discussion, whereas reviews, meta-analyses, guidelines, consensus statements, and authoritative reports were used principally for context. Evidence was synthesized qualitatively because study designs, populations, anatomical sites, assays, outcomes, and clinical purposes differed substantially; no new meta-analysis was performed. Results: The most developed longitudinal and screening evidence concerned cervical cancer, whereas evidence for several non-cervical sites was smaller and more heterogeneous. HPV16 was the most important genotype in most cancers examined. The role of HPV18 and other high-risk genotypes varied depending on the cancer site, tissue type, and geographic region. Most transient infections do not lead to cancer; however, persistent high-risk HPV infection, particularly HPV16, was associated with high-grade lesions and an increased risk of cancer. Vaccination was associated with a reduction in high-grade lesions and invasive cancer in population-based studies. Self-sampling and urine testing had practical value when individuals with positive results proceeded to triage, treatment, and follow-up. Conclusions: Three key questions exist for assessing the risk of HPV-associated cancers: Where has the persistent infection occurred? Which genotype is involved? And can the healthcare system intervene before progression to cancer? In cervical cancer, vaccination, screening, triage, and treatment are linked within the most developed prevention pathway. For anal cancer, prevention is more strongly focused on high-risk groups and diagnostic capacity. In oropharyngeal cancer, HPV is important for understanding etiology and prognosis, but there is still no established population screening pathway. Evidence for vaginal, vulvar, and penile cancers must be interpreted separately by site.
SN - 2077-0383
ER -